An association of pharmacy benefit managers (PBMs) is urging the federal government to encourage the development of electronic prescribing (e-prescribing) as a vehicle for promoting more widespread acceptance of costsaving generic drugs. In calling for the creation of "a national, uniform standard for electronic prescribing," a spokesman for the Pharmaceutical Care Management Association (PCMA) told Congress that e-prescribing "has great potential to improve quality and promote the use of generic alternatives."
The problem, however, is that "a patchwork of varying state e-prescribing lawsin addition to the new e-prescribing regulations contained in the Medicare Modernization Acthave created sometimes conflicting and duplicative rules," PCMA President Mark Merritt said. "The adoption of a national, uniform standard for e-prescribing laws would encourage physicians to prescribe generics over brands whenever clinically appropriate," Merritt told Congress.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs